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Abstract: We aim to identify specific areas of white matter (WM) and grey matter (GM), which pre-
dict disability progression and cognitive dysfunction after five years in patients with primary-pro-
gressive multiple sclerosis (PPMS). Thirty-two patients with early PPMS were assessed at baseline
and after five years on the Expanded Disability Status Scale (EDSS), and EDSS step-changes were
calculated. At year five, a subgroup of 25 patients and 31 healthy controls underwent a neuropsy-
chological assessment. Baseline imaging consisted of dual-echo (proton density and T2-weighted),
T1-weighted volumetric, and diffusion tensor imaging. Fractional anisotropy (FA) maps were created,
and fed into tract-based spatial statistics. To compensate for the potential bias introduced by WM
lesions, the T1 volumes underwent a lesion-filling procedure before entering a voxel-based mor-
phometry protocol. To investigate whether FA and GM volume predicted EDSS step-changes over
five years and neuropsychological tests scores at five years, voxelwise linear regression analyses
were performed. Lower FA in the splenium of the corpus callosum (CC) predicted a greater progres-
sion of disability over the follow-up. Lower FA along the entire CC predicted worse verbal memory,
attention and speed of information processing, and executive function at five years. GM baseline vol-
ume did not predict any clinical variable. Our findings highlight the importance of damage to the
interhemispheric callosal pathways in determining physical and cognitive disability in PPMS. Disrup-
tion of these pathways, which interconnect motor and cognitive networks between the two hemi-
spheres, may result in a disconnection syndrome that contributes to long-term physical and
cognitive disability. Hum Brain Mapp 34:1163–1172, 2013. VC 2012 Wiley Periodicals, Inc.
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INTRODUCTION
Quantitative magnetic resonance imaging (MRI) has the
potential to provide prognostic indicators of clinical dis-
ability and cognitive dysfunction for patients with pri-
mary-progressive multiple sclerosis (PPMS), whose disease
course can vary widely [Cottrell et al., 1999; Tremlett
et al., 2005]. Over recent years, diffusion tensor imaging
(DTI) [Basser et al., 1994] and volumetric MRI techniques
have been employed to establish the clinical relevance of
in-vivo brain white matter (WM) and grey matter (GM)
abnormalities [Bakshi et al., 2008]. In particular, fractional
anisotropy (FA), a DTI-derived measure [Basser et al.,
1994], has been extensively used to quantify the integrity
of WM tracts in MS; a reduction of this measure implies
demyelination and axonal loss, and, despite being a mea-
sure which is pathologically non-specific, it has been
shown to correlate significantly with cognitive scores in
MS [Roosendaal et al., 2009] and predict motor impair-
ment in relapsing-remitting MS [Kern et al., 2010]. With
regard to GM, the most commonly used measure is GM
volume, which, if reduced, reflects irreversible tissue loss
(or atrophy) [Miller et al., 2002], and has been demon-
strated to proceed relentlessly throughout the course of
MS [De Stefano et al., 2010] and be clinically relevant
[Fisher et al., 2008].
Several methods for detecting patient-control differences
based on MRI parameters are available. Tract-based spatial
statistics (TBSS) [Smith et al., 2006] and voxel-based mor-
phometry (VBM) [Ashburner and Friston, 2000] are able to
identify, respectively, WM regions of reduced FA and
areas of GM atrophy in patients when compared with
healthy controls. The advantage of these two techniques is
that they localize specific brain regions of WM damage
and GM volume loss in patients compared with healthy
controls by searching across the whole brain, without the
need to generate an a priori hypothesis. In a recent cross-
sectional study of patients with early PPMS (i.e., patients
who were studied within 5 years of symptom onset), we
combined these two techniques, and reported a reduced
FA in extensive WM regions including the whole corpus
callosum (CC) and the cortico-spinal tracts [Bodini et al.,
2009] in patients compared with healthy controls, and a
diffuse reduction in patients GM volume, in areas such as
the sensory-motor cortex bilaterally and the right superior
temporal gyrus. In a subsequent longitudinal study in the
same patient population, we employed magnetization
transfer imaging histogram and volumetric analyses of
WM and GM, and reported that WM lesion load is the
most important predictor of subsequent cognitive dysfunc-
tion, but whole GM MTR also contributed [Penny et al.,
2010]. Despite evidence of damage in both tissue compart-
ments, and of their role in the accumulation of disability,
it is unknown whether the factors responsible for clinical
progression in PPMS are the whole (diffuse) GM tissue pa-
thology or abnormalities in specific GM and WM regions,
above and beyond the contribution provided by WM
lesion load. This is an important question to address in
order to understand the mechanisms underlying clinical
deterioration, which is known to be quite variable in this
type of MS.
Here, we hypothesize that specific location of grey and
WM areas play a relevant role in predicting long-term
physical and cognitive disability in patients with early
PPMS. Therefore, we reanalyzed the same longitudinal
dataset obtained in our unique cohort of early PPMS
patients, and employed, for the first time, TBSS and VBM
to identify specific areas of WM and GM which predict
progression of physical disability over five years and cog-
nitive dysfunction after five years.
METHODS
Study Design
Thirty-two patients with PPMS [Thompson et al., 2000]
within five years of symptom onset (13 women, mean age
44.5 years, SD 10.3; see Table I for clinical, radiological,
and demographic characteristics) underwent a whole brain
imaging protocol, including diffusion sequences, and were
clinically assessed on the Expanded Disability Status Scale
(EDSS) [Kurtzke, 1983] at study entry. After five years,
they were again assessed on the EDSS and invited to
undergo an extensive neuropsychological assessment,
which was also performed on a group of healthy controls.
Neuropsychological Assessment
Out of 32 patients recruited at baseline, 25 [11 women,
mean age 51.3 years, (range 31–68), mean years of educa-
tion 13.0 (range 10–19)] underwent an extensive neuropsy-
chological assessment five years after entry into the study.
Out of the seven patients who were not cognitively
assessed, four male patients were too physically impaired
(they were very dysarthric and ataxic) to provide valid
results for a significant proportion of the tests, and there-
fore were excluded; one female and one male patient
declined to take part in the neuropsychological tests. The
remaining female patient was not contactable.
TABLE I. Patients’ clinical, radiological, and
demographic characteristics at baseline
Number 32
Age, mean (SD) 44.5 years (10.3)
Gender, female/male 13/19
Disease duration, mean (SD) 3.3 years (0.9)
EDSS, median (range) 4.5 (1.5–6.5)
T2 lesion load, ml, mean (SD) 23.5 (17.3)
Years of education,a mean (SD) 13 (2.9)
Premorbid IQ,a mean (SD) 109.4 (9.6)
aValues calculated on the subgroup of 25 patients who underwent
the neuropsychological testing at 5 years.
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Thirty-one age- and gender-matched healthy controls
[14 women, mean age 48.9 years, (range 30–65), mean
years of education 13.4 (range 10–19)] also underwent the
same neuropsychological tests. The exclusion criterion
applied to all subjects was a history of other neurological
or systemic illness, of impaired cognition, of psychiatric ill-
ness, of head injury resulting in loss of consciousness, or
of alcohol or drug abuse.
The cognitive assessment included the following tests:
(i) the National Adult Reading Test (NART) [Nelson,
1982], to estimate each patient’s premorbid intellectual
functioning; (ii) the immediate and delayed conditions of
the story (SRT) and figure recall (FRT) subtests of the
Adult Memory and Information Processing Battery
[Coughlan and Hollows, 1985], to assess verbal and visual
recall memory function; (iii) the Paced Auditory Serial
Addition Test (3-second version; PASAT-3) [Cutter et al.,
1999] and the Symbol Digit Modalities Test (SDMT)
[Smith, 1982], to evaluate attention and speed of informa-
tion processing; (iv) the Hayling Sentence Completion
Task (HSCT) [Burgess and Shallice, 1997], a test of verbal
response generation and inhibition, and the Brixton Spatial
Anticipation Test [Burgess and Shallice, 1997], a spatial
reasoning, rule detection and rule change task, to test exec-
utive functions.
Patients had not previously received any of these tests
with the exception of the PASAT, which had been admin-
istered up to seven times in earlier follow-ups.
This study was approved by the Joint Medical Ethics
Committee of the National Hospital for Neurology and
Neurosurgery, London. Written and informed consent was
obtained from all participants.
Processing of Clinical and Cognitive Data
Analysis was performed using Stata version 9.2 (Stata
Corporation, College Station, Texas) and results with a
P < 0.05 were considered significant.
Significant changes in EDSS between baseline and five
years were assessed using the Wilcoxon signed ranks test.
Since the EDSS is an ordinal (non-continuous scale), para-
metrical statistical methods cannot be used to analyze
changes in the EDSS score, and, for this reason, the mean
raw change in the EDSS score is considered to be an inap-
propriate statistical endpoint [Wingerchuk et al., 1997]. In
addition, the meaning of the changes in EDSS is not equiv-
alent throughout the scale. For example, the difference
between EDSS 0.5 and 1.0 is 0.5, as well as the difference
between EDSS 6.0 and 6.5 is 0.5; however, this 0.5 differ-
ence does not reflect the same extent of clinical deteriora-
tion. Finally, there is a variable mean duration at different
EDSS levels [Weinshenker et al., 1991]. Therefore, to assess
disability progression over the follow-up period, we fol-
lowed the recommendation to calculate the EDSS step-
change in each patient: one-step deterioration on the scale
was defined as an increase of 1 if the baseline EDSS was
less than or equal to 5, or an increase of 0.5 if it was
greater than 5. This approach is more sensitive in detect-
ing significant clinical deterioration in the upper part of
the scale (i.e., in more disabled patients), and has also
been recommended for clinical trials [Wingerchuk et al.,
1997].
As far as the neuropsychological scores are concerned,
the raw scores of all the measures, except premorbid IQ,
were converted to z-scores referenced to the control group,
and these multiplied by 1 when appropriate, so that a
lower score always indicated a poorer performance. A
z-score 2 in a test was considered to be abnormal. Age,
years of education, and premorbid IQ were compared
between patients and healthy controls using t-tests; gender
was compared between groups using a chi-square test. To
investigate the difference in cognitive performance
between patients and healthy controls, a multiple linear
regression model was used, entering each cognitive mea-
sure, in turn, as dependent variable, and a binary group
indicator, together with age, gender, years of education,
and premorbid IQ, as covariates. Since our primary goal
was to identify predictors of cognitive dysfunction, only
the neuropsychological test scores that showed a signifi-
cant difference between patients and healthy controls, or a
trend towards a difference (P < 0.08), were entered in the
subsequent steps of the analysis.
We have also tested for differences between male and
female patients in EDSS scores at 5 years, and in all neuro-
psychological tests scores, using Mann–Whitney test and
independent samples t tests, respectively.
Image Acquisition and Postprocessing
Patients were imaged at study entry using a 1.5T GE
Signa scanner (General Electrics, Milwaukee, IL). MRI ac-
quisition and protocol were as follows:
a. Fast spin echo scan collecting proton-density-
weighted (PD) and T2-weighted images [repetition
time (TR) 2000 ms, echo times (TEs) 17/92 ms, field
of view (FOV) 240  180 mm2, matrix size 256  256,
28 axial slices, 5-mm thickness]. Lesions were con-
toured on the PD images, with reference to the T2
images, using a semiautomated local contour thresh-
olding technique [Plummer, 1992], and the total
lesion load (LL) was calculated. In each patient, a
lesion mask was created.
b. Whole-brain, cardiac-gated, spin echo diffusion-
weighted echo planar imaging sequence [FOV 240 
240 mm2, matrix size 96  96 (reconstructed to 128 
128), image resolution 2.5  2.5  3 mm (recon-
structed to 1.9  1.9  3 mm), TE 95 ms, TR 7 RRs,
maximum b-factor 1000 smm2; three series, each col-
lecting 14 axial slices of 3-mm thickness, which were
interleaved off-line; diffusion gradients were applied
along 25 optimized directions, and three images with
no diffusion weighting were also acquired]. After
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correction for eddy-current induced distortions, the
diffusion tensor was calculated on a voxel-by-voxel
basis, and FA maps were generated using DTIfit, that
is part of the FMRIB Software Library 4.1 software
package (FSL, FMRIB Image Analysis Group, Oxford,
UK) [Smith et al., 2004]. FA maps were fed into TBSS
[Smith et al., 2006], to obtain a projection of all sub-
jects’ FA data onto a mean FA tract skeleton. We
used the FSL FA atlas as a target for non-linear regis-
tration, while the mean FA of our patients was used
to generate the mean skeleton, as recommended by
the FSL website (www. fmrib.ox.ac.uk/fsl/tbss).
c. Three-dimensional inversion-recovery fast spoiled
gradient recall (3D FSPGR) T1-weighted (T1-w)
sequence of the brain [FOV 300  225 mm, matrix
size 256  160 (reconstructed to 256  256 for a final
in plane resolution of 1.17 mm), TR 13.3 ms, TE 4.2
ms, inversion time 450 ms, 124 axial slices, 1.5-mm
thickness].
The SPGR volumes were segmented and normalized to
obtain GM, WM, and cerebro-spinal fluid volumes using
SPM8 software (Wellcome Department of Cognitive Neu-
rology, London, UK), according to the VBM protocol [Ash-
burner and Friston, 2005]. This protocol consists of an
iterative combination of segmentations and normalizations
and produced a GM probability map. As the presence of
WM lesions is known to significantly affect brain segmen-
tation [Nakamura and Fisher, 2009] and registration [Sdika
and Pelletier, 2009], which are key steps in VBM, we
applied the recently developed lesion-automated prepro-
cessing (lesion-automated preprocessing, LEAP) [Chard
et al., 2010] technique to the T1w images, before feeding
them into the VBM procedure. Briefly, LEAP is an
‘‘in-painting’’ technique, which replaces lesional voxels
with values derived from the intensity distribution within
the WM outside visible lesions in the presegmentation
phase [Chard et al., 2010]. This technique minimizes
lesion-associated segmentation biases, which may signifi-
cantly affect VBM results. As the smoothing kernel sensi-
tizes the analysis to differences of comparable size as the
kernel [Rosenfeld and Kak, 1982], GM images were modu-
lated and smoothed using both 12-mm FWHM and 8-mm
FWHM Gaussian kernels.
Investigation of Predictors of Physical
Deterioration and Cognitive Dysfunction
White matter FA analysis
To investigate whether FA was associated with EDSS
step-change and neuropsychological tests scores, a voxel-
wise linear regression analysis was performed, adjusting
for age, gender, years of education, and NART (the last
two variables were used only when predicting neuropsy-
chological scores). As mentioned above, only tests that
identified abnormality in patients compared with healthy
controls were used. The analysis was based on permuta-
tion-based inference, and corrected for multiple compari-
sons using Threshold-Free Cluster Enhancement (TFCE; P
< 0.05) [Smith and Nichols, 2009].
To investigate the effect of gender on significant find-
ings, the voxel-wise linear regression analysis was
repeated by modelling the interaction between gender
(male or female) and each clinical and neuropsychological
score, using permutation-based inference, and correcting
for multiple comparisons using TFCE (P < 0.05).
To understand the contribution of WM lesions to the
results, where significant associations were found between
baseline FA and clinical/neuropsychological variable, the
regression analysis was repeated by including, in turn, the
total LL and the tract-specific LL, as additional covariate.
This tract-specific LL was calculated by using the Johns
Hopkins University WM tractography atlas, provided by
FSL [Mori et al., 2005], which provides a probabilistic
reconstruction of the main WM tracts. Each subject’s T2-
weighted scan was coregistered with the atlas, and the
same transformation was applied to the lesion mask.
Lesions belonging to a specific tract were identified to
obtain the tract-specific LL.
Grey matter volumetric analysis
A voxel-wise multiple regression analysis was used to
investigate the association between regional GM volume
and EDSS step-change and neuropsychological tests,
adjusting for the same variables as those used for TBSS,
and correcting for multiple comparisons with family-wise
error rate. P-values <0.05 were considered to be
significant.
RESULTS
Patients’ Clinical and Neuropsychological
Assessment
Patients showed progression of disability on the EDSS
during the follow-up period [median EDSS at baseline ¼
4.5 (range 1.5–6.5), at 5 years ¼ 6.4 (range 1.5–9), P ¼
0.001].
There were no significant differences between patients
and healthy controls in age, gender, years of education, or
premorbid IQ. The neuropsychological test results, the
number of patients who failed on each test, and the com-
parison between patient and control groups in all tests are
summarized in e-Table I (Supporting Information), and
have been previously reported in detail [Penny et al.,
2010]. Eighteen patients had abnormal scores on at least
one test (six patients failed on one test only, six on two
tests, and six on three or more tests). The neuropsychologi-
cal tests on which patients performed significantly worse
than healthy controls, and which were therefore retained
for the subsequent part of the analysis, were the
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immediate and delayed story recall tests (SRT) and figure
recall tests, the SDMT, and the HSCT.
There was no significant difference between male and
female patients in EDSS scores at 5 years, and in all neuro-
psychological tests scores.
White Matter FA As Predictor
When looking for a significant association between FA
across the whole skeleton and disability progression, a lower
baseline FA in the splenium of the CC was found to be asso-
ciated with greater progression of disability over five years,
as measured by the EDSS step-change (MNI coordinates, x ¼
83, y ¼ 90, z ¼ 92, no. voxels ¼ 8307, P < 0.05) (see Fig. 1).
With regard to the prediction of cognitive dysfunction,
the strongest (and most consistent) association between
lower FA at baseline and worse cognitive performance at
five years was found in the CC (see Table II for cluster
sizes and coordinates). In particular: (i) lower FA in the
splenium and genu of the CC was associated with worse
immediate verbal memory function, as measured by the
immediate SRT (P ¼ 0.003; Fig. 2A); (ii) lower FA in the
splenium, body, and genu of the CC (with extension into
the right thalamic radiation) was associated with worse
delayed verbal memory function, as measured by the
delayed SRT (P ¼ 0.003); (iii) lower FA in the body and
splenium of the CC was associated with worse attention
and speed of information processing, as measured by the
SDMT (P < 0.05; Fig. 2B); (iv) lower FA in the genu and
body of the CC (and in the bilateral corona radiata) was
associated with worse executive functions, as measured by
the HSCT (P ¼ 0.003; Fig. 2C).
When less stringent thresholds for significance were
used (P < 0.05), associations between FA and the
Figure 1.
The callosal regions along the TBSS skeleton, whose FA at study entry was associated with pro-
gression of physical disability over 5 years, are shown in blue and overlaid onto the patients’
mean FA image (P < 0.05).
TABLE II. White matter regions showing a significant association between lower baseline FA







coordinates x, y, z Significant regions P value
Immediate Story Recall Test 6025 106, 82, 80 Splenium of CC P ¼ 0.003
1084 74, 171, 59 Anterior part of genu of CC
Delayed Story Recall Test 4471 105, 84, 80 Splenium of CC P ¼ 0.003
2466 69, 173, 71 Anterior part of right thalamic
radiation and genu of CC
651 103, 112, 105 Body of CC
Symbol Digit Modalities Test 2265 94, 104, 97 Body of CC P ¼ 0.05
86 99, 84, 86 Splenium of CC
Hayling Sentence Completion Task 1065 76, 161, 84 Genu of CC P ¼ 0.003
873 56, 80, 102 Right posterior corona radiata
456 107, 71, 121 Left posterior corona radiata
243 91, 135, 95 Body of CC
177 78, 122, 100 Body of CC
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immediate and delayed SRT and HSCT were also found in
multiple areas of the skeleton, including the frontal and
parietal WM (Fig. 1, Supporting Information) and the
brainstem.
No significant gender-related differences in the EDSS
and neuropsychological tests at five years were seen; no
significant interactions between gender and EDSS or neu-
ropsychological score were found.
Contribution of WM Lesions
When repeating the analyses adjusting for total LL, the
association between lower FA in the genu and body of the
CC and the executive functions (HSCT) at five years remained
significant (P < 0.05), whilst the associations between FA and
disability progression and the performance on immediate and
delayed verbal memory tests (SRT) and attention and speed
of information processing (SDMT) did not.
The mean volume of lesions localized in the CC (the
region that showed the strongest association with clinical
and neuropsychological variables) was 1.3 cc (SD1.47).
When repeating the analyses adjusting for this CC lesion
load, FA in the splenium of the CC no longer predicted
disability progression, and lower FA in the splenium and
body of the CC no longer predicted a poorer performance
in attention and speed of information processing (SDMT).
By contrast, the FA of the splenium of the CC at study
entry remained significantly associated with a worse per-
formance on immediate and delayed verbal memory tests
(SRT; P < 0.05), and the FA of the body of the CC was
associated with a poorer performance on a test of execu-
tive function (HSCT; P < 0.05) (Fig. 3) at five years.
Gray Matter Volume As Predictor
Baseline GM volume did not significantly predict EDSS
step-change or any cognitive impairment at five years
(with either 8-mm or 12-mm FWHM smoothing Kernel).
DISCUSSION
We applied a combination of TBSS and VBM (after a
lesion-filling procedure) to the baseline FA and volumetric
scans of patients with early PPMS. We found that the
baseline FA of the CC, previously shown to be reduced in
the same cohort of patients compared to that of healthy
controls [Bodini et al., 2009], was significantly associated
with long-term progression of physical disability, as meas-
ured by the EDSS step-change, and the occurrence of cog-
nitive dysfunction at 5 years, in the domains of immediate
and delayed verbal memory, executive function, and atten-
tion and speed of information processing, where patients
performed significantly worse than controls. These find-
ings were interpreted as indicative that lower CC FA at
baseline was a predictor of both disability progression and
cognitive dysfunction at five years. Future studies will
Figure 3.
The callosal area, whose FA at baseline significantly correlated
with executive function scores (HSCT) at 5 years, after adjusting
for corpus callosum T2 lesion load, is displayed in pink (P <
0.05) and overlaid onto the patients’ mean FA image.
Figure 2.
The callosal areas, whose FA at study entry was associated with immediate verbal memory
scores (as measured by SRT, P < 0.003), are shown in blue (A), those predicting attention and
speed of information processing scores (SDMT, P < 0.05) at 5 years in green (B), and those
whose FA was associated with executive function scores (as measured by HSCT, P < 0.003) are
shown in red (C), and overlaid onto the patients’ mean FA image.
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address the question whether CC FA is also relevant to
the progression of cognitive impairment, which has been
reported in MS [Langdon, 2011].
The CC ensures effective communication between motor
and cognitive networks in the two hemispheres [Bogen
et al., 1965]; in particular, the anterior parts of the CC (ros-
trum and genu) connect the orbitofrontal, lateral and
medial frontal cortices, whereas the body and splenium
connect parietal, temporal, and occipital homotopic
regions [Abe et al., 2004]. The primary motor cortices, nec-
essary for performing highly skilled motor movements,
and several premotor areas, involved together with the
supplementary motor areas in the initiation, planning, and
regulation of movement, are connected between hemi-
spheres through the CC [Chao et al., 2009]; the disconnec-
tion of these motor networks has been shown to result in
a deterioration of motor function and upper limb function
[Kern et al., 2010; Ozturk et al., 2010; Srikanth et al., 2010].
In our cohort, we found that lower FA in the splenium of
the CC predicted the accumulation of motor disability
over the follow-up period and, similarly, the raw EDSS at
5 years (P ¼ 0.02; results not shown). The splenium of the
CC is known to interconnect temporal and occipital corti-
ces [Park et al., 2008], mainly underlying the transfer of
auditory and visual information. However, the connections
between its superior segment and Brodmann’s area 5
[Chao et al., 2009], which is implicated in the earliest
stages of sophisticated movement planning [Andersen and
Buneo, 2002], could explain why its early damage predicts
long-term disability progression in our patients.
Furthermore, the correlation we found between a lower
baseline FA of the CC and a worse cognitive performance
at 5 years, extends previous findings on the relevant role
of the CC in ensuring effective interhemispheric coopera-
tion, which is necessary to perform cognitive tasks that
require the activation of cortical areas in both hemi-
spheres. In particular, considerable evidence from func-
tional neuroimaging studies showed that bilateral
temporo-parietal cortices are implicated in performing epi-
sodic memory tests [Buckner and Wheeler, 2001; Rugg
et al., 2002], and that complex tasks, such as those related
to attention/speed of information processing, and execu-
tive function, require bilateral frontal and parietal involve-
ment [Buchsbaum et al., 2005; Gazzaniga, 2005]. Evidence
from several cross-sectional studies investigating different
subject populations supports our findings [Jokinen et al.,
2007; Voineskos et al., 2010]. For example, a reduction in
the WM integrity of the splenium correlated with worse
age-related memory and executive function in a sample of
53 healthy subjects [Voineskos et al., 2010], and atrophy of
the CC fibers correlated with poor performance in tests
assessing speed of mental processing, and attention and
executive functions, in patients with age-related white-
matter hyperintensities [Jokinen et al., 2007]. Cross-sec-
tional studies have demonstrated that tissue damage local-
ized in the CC plays a role in contributing to concurrent
motor disability and cognitive dysfunction in different
phenotypes of MS [Kern et al., 2010; Mesaros et al., 2009;
Ozturk et al., 2010]. We have now extended these results
by demonstrating that CC damage has an important role
in predicting long-term disability. The underlying mecha-
nism may be the occurrence of a disconnection syndrome
[He et al., 2009], whereby damage to structural connectiv-
ity [either through focal lesions or normal appearing white
matter (NAWM) pathology] may, in turn, lead to an
altered functional connectivity between GM regions and,
ultimately, to clinical impairment [Dineen et al., 2009] and
cognitive dysfunction [Dineen et al., 2009] in MS. The pos-
sibility of a disconnection syndrome is further supported
by the findings that, when lower thresholds for signifi-
cance were used for the analysis, the association between
FA and cognitive performance on immediate and delayed
verbal memory tests (SRT) and executive functions (HSCT)
was found to extend to multiple regions of the skeleton,
including frontal, temporal, and parietal WM, which are
regions involved in memory [Buckner and Wheeler, 2001;
Rugg et al., 2002] and executive function [Buchsbaum
et al., 2005; Gazzaniga, 2005]. The finding of significant
association between FA of the brainstem and executive
function suggests that the disruption to brain stem-hemi-
sphere interactions may further contribute to the discon-
nection syndrome, in agreement with reports of cognitive
dysfunction in patients with isolated brain stem insult
[Garrard et al., 2002].
When the association between FA and cognitive per-
formance was corrected for total lesion load, FA in the
genu and body of the CC remained significantly associated
with performance on a executive function test (HSCT);
similarly, FA of the body of the CC still predicted per-
formance on the HSCT when adjusting for callosal lesion
load (LL). Whilst the association between genu FA and ex-
ecutive function is expected to remain significant despite
correction for the total LL, the association between more
posterior portions of the CC and the performance on the
HSCT is less obvious. The HSCT score is determined to
some extent by general speed, and involves verbal proc-
essing and word generation. These cognitive functions
require an effective interhemispheric connection between
temporal and parietal cortical areas that are connected
through more posterior regions of the CC. When adjusting
for callosal LL, FA in the splenium of the CC predicted
performance on immediate and delayed verbal memory
tests (SRT), confirming that the reduced integrity of poste-
rior callosal regions is linked to verbal memory dysfunc-
tion independently of local lesions. Overall, this
persistence of significant correlations between FA and cog-
nitive performance after corrections for LL supports the
important role played by the normal-appearing WM
(NAWM) damage in contributing to cognitive dysfunction
[Mesaros et al., 2009] in MS; as previously hypothesised,
the injury to the NAWM of the CC may result from a
degeneration of axons transected in local T2 lesions and
distal lesions whose related fibers cross the CC, through a
mechanism of Wallerian degeneration [Coombs et al.,
r Callosal Damage Predicts Disability in PPMS r
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2004; Dziedzic et al., 2010; Mesaros et al., 2009]. However,
the contribution of GM injury and primary damage to
axons (i.e., primary axonopathy) [Geurts et al., 2010] to
axonal degeneration in the NAWM has yet to be conclu-
sively established.
In our previous work on this same cohort, where we
analyzed with a traditional approach the whole WM and
GM matter histogram metrics and volumes, we found that
whole brain GM MTR predicted the PASAT score,
whereas whole brain GM and WM volume predicted per-
formance on the Brixton test [Penny et al., 2010]. Here, the
scores on both the PASAT and the Brixton have been
excluded from the analysis, as they did not differ signifi-
cantly between patients and healthy controls. Rather sur-
prisingly, in the present study, we did not find any GM
region that significantly predicted clinical outcome, when
using a VBM approach. Since the extent of the areas being
investigated is in principal unknown, we used two differ-
ent smoothing kernels, but the results were consistently
negative. The pathological correlates of GM atrophy are
still unclear, and may reflect demyelination, loss of den-
drites, axons, and synapses, possibly in combination. Even
in early PPMS patients, GM atrophy has been identified in
the precentral and postcentral gyri, and in the temporal
cortex, and this has been reported to be relevant for con-
current clinical disability [Bodini et al., 2009; Khaleeli
et al., 2007].
The lack of correlation between GM atrophy and disabil-
ity progression is in contrast with the results of other stud-
ies, performed on patients with other forms of MS
[Jasperse et al., 2007]. This could be a consequence of the
regional distribution of atrophy in PPMS, which seems to
differ from the pattern described in other forms of MS
when using VBM [Ceccarelli et al., 2008]. This difference
in regional distribution of atrophic GM areas could per-
haps help to explain the lack of significant association
between regional GM volumes at baseline and long-term
clinical outcomes in our cohort of PPMS. Moreover, in
RRMS, it has been reported a significant correlation
between early changes in regional GM volume and clinical
outcome [Jasperse et al., 2007]. It is possible that looking at
regional changes in GM volume, rather than using base-
line regional GM volumes only, as we did in this study,
could prove more useful in finding significant correlations
with long-term clinical outcomes. Finally, when investigat-
ing potential predictive measures of clinical outcome, MRI
measures other than GM volume, for example those able
to explore the microstructural damage occurring in the
early stage of the disease, such as MTR, or sequences that
allow detection of GM lesions, may provide significant
results. In addition, it would be of a great interest to inves-
tigate whether there is a temporal relationship between
WM abnormalities and GM changes, and whether this
changes across brain regions and types of MS. From a
technical point of view, in this work we used a novel
approach to remove lesion-related segmentation bias
before VBM. Preliminary results of the applications of this
method show that without region filling, the GM volume
is in general overestimated (because the WM lesions have
signal intensity similar to that of the cortex) [Chard et al.,
2010]. Therefore, the application of this method should
ensure that the segmented GM does not include the
lesional tissue.
In conclusion, this study has provided insights into the
mechanisms of progression in PPMS, by showing that
early damage localized the CC is a relevant determinant of
progression of motor disability and future cognitive dys-
function in this patient group. Disconnection of relevant
brain regions is proposed as a potential mechanism of clin-
ical progression in MS.
ACKNOWLEDGEMENTS
The authors are very grateful to all the patients for tak-
ing part in the study. This work was undertaken at
UCLH/UCL who received a proportion of funding from
the Department of Health’s NIHR Biomedical Research
Centres funding scheme.
REFERENCES
Abe O, Masutani Y, Aoki S, Yamasue H, Yamada H, Kasai K,
Mori H, Hayashi N, Masumoto T, Ohtomo K (2004): Topogra-
phy of the human corpus callosum using diffusion tensor trac-
tography. J Comput Assist Tomogr 28:533–539.
Andersen RA, Buneo CA (2002): Intentional maps in posterior pa-
rietal cortex. Annu Rev Neurosci 25:189–220.
Ashburner J, Friston KJ (2000): Voxel-based morphometry—The
methods. Neuroimage 11:805–821.
Ashburner J, Friston KJ (2005): Unified segmentation. Neuroimage
26:839–851.
Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, Bar-
khof F, Inglese M, Guttmann CR, Horsfield MA, Filippi M
(2008): MRI in multiple sclerosis: Current status and future
prospects. Lancet Neurol 7:615–625.
Basser PJ, Mattiello J, LeBihan D (1994): Estimation of the effective
self-diffusion tensor from the NMR spin echo. J Magn Reson B
103:247–254.
Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ,
Ciccarelli O (2009): Exploring the relationship between white
matter and gray matter damage in early primary progressive
multiple sclerosis: An in vivo study with TBSS and VBM.
Hum Brain Mapp 30:2852–2861.
Bogen JE, Fisher ED, Vogel PJ (1965): Cerebral commissurotomy.
A second case report. JAMA 194:1328–1329.
Buchsbaum BR, Greer S, Chang WL, Berman KF (2005): Meta-
analysis of neuroimaging studies of the Wisconsin card-sorting
task and component processes. Hum Brain Mapp 25:35–45.
Buckner RL, Wheeler ME (2001): The cognitive neuroscience of
remembering. Nat Rev Neurosci 2:624–634.
Burgess PW, Shallice T (1997): The Hayling and Brixton Tests.
Bury St. Edmunds: Thames Valley Test Company.
Ceccarelli A, Rocca MA, Pagani E, Colombo B, Martinelli V, Comi
G, Filippi M (2008): A voxel-based morphometry study of grey
matter loss in MS patients with different clinical phenotypes.
Neuroimage 42:315–322.
r Bodini et al. r
r 1170 r
Chao YP, Cho KH, Yeh CH, Chou KH, Chen JH, Lin CP (2009):
Probabilistic topography of human corpus callosum using
cytoarchitectural parcellation and high angular resolution
diffusion imaging tractography. Hum Brain Mapp 30: 3172–3187.
Chard DT, Jackson JS, Miller DH, Wheeler-Kingshott CA (2010):
Reducing the impact of white matter lesions on automated
measures of brain gray and white matter volumes. J Magn
Reson Imaging 32:223–228.
Coombs BD, Best A, Brown MS, Miller DE, Corboy J, Baier M,
Simon JH (2004): Multiple sclerosis pathology in the normal
and abnormal appearing white matter of the corpus callosum
by diffusion tensor imaging. Mult Scler 10:392–397.
Cottrell DA, Kremenchutzky M, Rice GP, Koopman WJ, Hader W,
Baskerville J, Ebers GC (1999): The natural history of multiple
sclerosis: A geographically based study. V. The clinical fea-
tures and natural history of primary progressive multiple scle-
rosis. Brain 122 (Part 4):625–639.
Coughlan AK, Hollows AK (1985): The Adult Memory and Infor-
mation Processing Battery. Leeds: St James’s University Hospi-
tal, AK Coughlan.
Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau
J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Elli-
son GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson
A, Willoughby E (1999): Development of a multiple sclerosis
functional composite as a clinical trial outcome measure. Brain
122 (Part 5):871–882.
De Stefano N, Giorgio A, Battaglini M, Rovaris M, Sormani MP,
Barkhof F, Korteweg T, Enzinger C, Fazekas F, Calabrese M,
Dinacci D, Tedeschi G, Gass A, Montalban X, Rovira A,
Thompson A, Comi G, Miller DH, Filippi M (2010): Assessing
brain atrophy rates in a large population of untreated multiple
sclerosis subtypes. Neurology 74:1868–1876.
Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, Constan-
tinescu CS, Auer DP (2009): Disconnection as a mechanism for
cognitive dysfunction in multiple sclerosis. Brain 132:239–249.
Dziedzic T, Metz I, Dallenga T, Konig FB, Muller S, Stadelmann
C, Bruck W (2010): Wallerian degeneration: A major compo-
nent of early axonal pathology in multiple sclerosis. Brain
Pathol 20:976–985.
Fisher E, Lee JC, Nakamura K, Rudick RA (2008): Gray matter at-
rophy in multiple sclerosis: A longitudinal study. Ann Neurol
64:255–265.
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